ReviewCancers2025

Exploring the Potential of Adjuvant CDK4/6 Inhibitors in Hormone Receptor-Positive Early Breast Cancer: A Consistent Approach for All.

Jianbin LiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.